Neurology and Neurosurgery - Global Neurology Academy

Episodes 33-48 of 364

Exploring IGF1R as a New Therapeutic Target in Myasthenia Gravis
Exploring IGF1R as a New Therapeutic Target in Myasthenia Gravis
NeuroFrontiers
Exploring IGF1R as a New Therapeutic Target in Myasthenia Gravis
Improving Diagnostic Accuracy in MS: Criteria, Challenges, and Innovations
Improving Diagnostic Accuracy in MS: Criteria, Challenges, and Innovations
NeuroFrontiers
Improving Diagnostic Accuracy in MS: Criteria, Challenges, and Innovations
- Andrew J. Solomon, MD
Advancing CIDP Research: Targeted Therapies, AI Integration, and Immunological Insights
Advancing CIDP Research: Targeted Therapies, AI Integration, and Immunological Insights
Global Neurology Academy
Advancing CIDP Research: Targeted Therapies, AI Integration, and Immunological Insights
- Karissa Gable, MD
Optimizing Neuromuscular Disease Care: How to Assess and Address Respiratory Risks
Optimizing Neuromuscular Disease Care: How to Assess and Address Respiratory Risks
NeuroFrontiers
Optimizing Neuromuscular Disease Care: How to Assess and Address Respiratory Risks
- Charles Turck, PharmD, BCPS, BCCCP
- Jason Ackrivo, MD, MSCE
- Bethany Lussier, MD
Enhancing Multiple Sclerosis Care Through Digital Cognitive Assessment
Enhancing Multiple Sclerosis Care Through Digital Cognitive Assessment
On the Frontlines of Multiple Sclerosis
Enhancing Multiple Sclerosis Care Through Digital Cognitive Assessment
- Mark Gudesblatt, MD
Harnessing Neuroplasticity: Timing and Intensity in Post-Stroke Aphasia Intervention
Harnessing Neuroplasticity: Timing and Intensity in Post-Stroke Aphasia Intervention
NeuroFrontiers
Harnessing Neuroplasticity: Timing and Intensity in Post-Stroke Aphasia Intervention
- Kelly Sloane, MD
Inflammatory Gateways: Exploring the Role of the Choroid Plexus in Post-TBI Care
Inflammatory Gateways: Exploring the Role of the Choroid Plexus in Post-TBI Care
NeuroFrontiers
Inflammatory Gateways: Exploring the Role of the Choroid Plexus in Post-TBI Care
- Prajwal Ciryam, MD, PhD
Gut Microbiota and Pediatric MS: New Insights Into Potential Disease Drivers
Gut Microbiota and Pediatric MS: New Insights Into Potential Disease Drivers
NeuroFrontiers
Gut Microbiota and Pediatric MS: New Insights Into Potential Disease Drivers
MS Management: Strategies for Ensuring Equitable Access to Teleneurology
MS Management: Strategies for Ensuring Equitable Access to Teleneurology
On the Frontlines of Multiple Sclerosis
MS Management: Strategies for Ensuring Equitable Access to Teleneurology
- Marisa McGinley, DO
Managing MS in Older Adults: Key Considerations for DMTs and Lifestyle Interventions
Managing MS in Older Adults: Key Considerations for DMTs and Lifestyle Interventions
On the Frontlines of Multiple Sclerosis
Managing MS in Older Adults: Key Considerations for DMTs and Lifestyle Interventions
- Charles Turck, PharmD, BCPS, BCCCP
- Kimberly DiMauro, DO
- Carol Swetlik, MD
Mapping Brain Atrophy in Schizophrenia
Mapping Brain Atrophy in Schizophrenia
Neurology and Neurosurgery
Mapping Brain Atrophy in Schizophrenia
- Ahmed Makhlouf, MD
Aging and Multiple Sclerosis: Insights from the 2024 CMSC Consensus Statement
Aging and Multiple Sclerosis: Insights from the 2024 CMSC Consensus Statement
On the Frontlines of Multiple Sclerosis
Aging and Multiple Sclerosis: Insights from the 2024 CMSC Consensus Statement
- Charles Turck, PharmD, BCPS, BCCCP
- Yinan Zhang, MD
- Sarah A. Morrow, MD, MS, FRCPC, FAAN
Optimizing Schizophrenia Care: Strategies for Managing Side Effects and Treatment Resistance
Optimizing Schizophrenia Care: Strategies for Managing Side Effects and Treatment Resistance
Global Neurology Academy
Optimizing Schizophrenia Care: Strategies for Managing Side Effects and Treatment Resistance
- Joseph F. Goldberg, MD
Understanding Schizophrenia: Early Intervention and Prevention Strategies
Understanding Schizophrenia: Early Intervention and Prevention Strategies
Global Neurology Academy
Understanding Schizophrenia: Early Intervention and Prevention Strategies
- Joseph F. Goldberg, MD
Studying Cortical Lesions in MS: Future Research Directions
Studying Cortical Lesions in MS: Future Research Directions
NeuroFrontiers
Studying Cortical Lesions in MS: Future Research Directions
- Michael G. Dwyer, PhD
Reducing Cortical Lesions in MS with Ocrelizumab: Results from the ORATORI Study
Reducing Cortical Lesions in MS with Ocrelizumab: Results from the ORATORI Study
NeuroFrontiers
Reducing Cortical Lesions in MS with Ocrelizumab: Results from the ORATORI Study
- Michael G. Dwyer, PhD

3/8